The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19.

Jiménez-Soto, Rodolfo; Aguilar-Soto, Mercedes; Rodríguez-Toledo, Carlos Andrés; Camiro-Zúñiga, Antonio; Demichelis, Roberta

Jiménez-Soto, Rodolfo; Aguilar-Soto, Mercedes; Rodríguez-Toledo, Carlos Andrés; Camiro-Zúñiga, Antonio; Demichelis, Roberta.

Afiliação

Jiménez-Soto R; Internal Medicine, ABC Medical Center, Mexico City, Mexico. Electronic address: jsrodo25@gmail.com.
Aguilar-Soto M; Internal Medicine, ABC Medical Center, Mexico City, Mexico.
Rodríguez-Toledo CA; Internal Medicine, ABC Medical Center, Mexico City, Mexico.
Camiro-Zúñiga A; Internal Medicine, ABC Medical Center, Mexico City, Mexico.
Demichelis R; Hematology, ABC Medical Center, Mexico City, Mexico.

Thromb Res ; 202: 14-16, 2021 06.

Article em En | MEDLINE | ID: mdl-33711753

Assuntos

COVID-19; Anticoagulantes/farmacologia; Anticoagulantes/uso terapêutico; Coagulação Sanguínea; Enoxaparina/farmacologia; Humanos; SARS-CoV-2

Palavras-chave

Anticoagulation; COVID-19; Enoxaparin; Thrombosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Thromb Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google